Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
antigen, attenuator, Calypso, celiac, circulating, consumption, costimulatory, DC, differentiate, disability, eosinophilic, inflamed, inhibitory, lymphocyte, migration, modality, molecule, NK, periphery, preferentially, primed, proven, repayment, rocatinlimab
Removed:
collective, dysregulation, Merck, myeloid, Pandion, remained, worked
Filing tables
Filing exhibits
Related press release
ANAB similar filings
Filing view
External links
![slide1](https://capedge.com/proxy/10-Q/0001370053-23-000049/anaptysbioinc-derestated001.jpg)
Delaware The First State Page 1 4062359 8100 Authentication: 203663607 SR# 20232896198 Date: 06-30-23 You may verify this certificate online at corp.delaware.gov/authver.shtml I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE RESTATED CERTIFICATE OF “ANAPTYSBIO, INC.”, FILED IN THIS OFFICE ON THE TWENTY-NINTH DAY OF JUNE, A.D. 2023, AT 7:21 O`CLOCK P.M.
![slide2](https://capedge.com/proxy/10-Q/0001370053-23-000049/anaptysbioinc-derestated002.jpg)
![slide3](https://capedge.com/proxy/10-Q/0001370053-23-000049/anaptysbioinc-derestated003.jpg)
![slide4](https://capedge.com/proxy/10-Q/0001370053-23-000049/anaptysbioinc-derestated004.jpg)
![slide5](https://capedge.com/proxy/10-Q/0001370053-23-000049/anaptysbioinc-derestated005.jpg)
![slide6](https://capedge.com/proxy/10-Q/0001370053-23-000049/anaptysbioinc-derestated006.jpg)
![slide7](https://capedge.com/proxy/10-Q/0001370053-23-000049/anaptysbioinc-derestated007.jpg)